Centessa Pharmaceuticals’ (CNTA) “Overweight” Rating Reiterated at Morgan Stanley
Morgan Stanley reaffirmed their overweight rating on shares of Centessa Pharmaceuticals (NASDAQ:CNTA – Free Report) in a research report report published on Friday,Benzinga reports. The firm currently has a $27.00 price objective on the stock. A number of other analysts have also recently commented on CNTA. TD Cowen started coverage on shares of Centessa Pharmaceuticals […]
Morgan Stanley reaffirmed their overweight rating on shares of Centessa Pharmaceuticals (NASDAQ:CNTA – Free Report) in a research report report published on Friday,Benzinga reports. The firm currently has a $27.00 price objective on the stock. A number of other analysts have also recently commented on CNTA. TD Cowen started coverage on shares of Centessa Pharmaceuticals […]
